Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.
Ji L, Hu D, Pan C, Weng J, Huo Y, Ma C, Mu Y, Hao C, Ji Q, Ran X, Su B, Zhuo H, Fox KA, Weber M, Zhang D; CCMR Advisory Board; CCMR-3B STUDY Investigators.
Ji L, et al. Among authors: weng j.
Am J Med. 2013 Oct;126(10):925.e11-22. doi: 10.1016/j.amjmed.2013.02.035. Epub 2013 Jun 27.
Am J Med. 2013.
PMID: 23810406